Stocks and Investing Stocks and Investing
Thu, June 23, 2022
Wed, June 22, 2022

Mark Massaro Initiated (AKYA) at Strong Buy and Held Target at $16 on, Jun 22nd, 2022


Published on 2024-10-27 21:34:57 - WOPRAI, Mark Massaro
  Print publication without navigation


Mark Massaro of BTIG, Initiated "Akoya Biosciences, Inc." (AKYA) at Strong Buy and Held Target at $16 on, Jun 22nd, 2022.

Mark has made no other calls on AKYA in the last 4 months.



There are 2 other peers that have a rating on AKYA. Out of the 2 peers that are also analyzing AKYA, 0 agree with Mark's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mark


  • David Westenberg of "Piper Sandler" Maintained at Buy with Decreased Target to $14 on, Monday, May 16th, 2022
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $18 on, Monday, May 9th, 2022
Contributing Sources